A detailed history of Magnetar Financial LLC transactions in Novartis Ag stock. As of the latest transaction made, Magnetar Financial LLC holds 1,906,046 shares of NVS stock, worth $197 Million. This represents 4.93% of its overall portfolio holdings.

Number of Shares
1,906,046
Previous 1,239,942 53.72%
Holding current value
$197 Million
Previous $125 Million 47.27%
% of portfolio
4.93%
Previous 4.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $63.5 Million - $72.3 Million
666,104 Added 53.72%
1,906,046 $184 Million
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $40.6 Million - $44.7 Million
440,244 Added 55.05%
1,239,942 $125 Million
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $44.5 Million - $49.4 Million
469,986 Added 142.54%
799,698 $81.5 Million
Q2 2023

Aug 11, 2023

BUY
$92.52 - $104.91 $30.5 Million - $34.6 Million
329,712 New
329,712 $33.3 Million
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $13.5 Million - $15.9 Million
-161,379 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $4.82 Million - $5.83 Million
-61,777 Reduced 27.68%
161,379 $15.2 Million
Q3 2020

Nov 16, 2020

BUY
$82.14 - $91.0 $12.5 Million - $13.8 Million
152,036 Added 213.77%
223,156 $19.4 Million
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $5.76 Million - $6.48 Million
71,120 New
71,120 $6.21 Million
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $14.9 Million - $20.8 Million
-210,182 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$84.35 - $95.37 $13.2 Million - $14.9 Million
156,182 Added 289.23%
210,182 $19.9 Million
Q3 2019

Nov 14, 2019

BUY
$85.54 - $94.26 $342,160 - $377,040
4,000 Added 8.0%
54,000 $4.69 Million
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $377,000 - $464,000
5,000 Added 11.11%
50,000 $4.57 Million
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $3.39 Million - $3.88 Million
45,000 New
45,000 $4.33 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.